NYON, Switzerland, April 9, 2009 (GLOBE NEWSWIRE) -- Mymetics (www.mymetics.com) Corporation (OTCBB:MYMX) is pleased to announce that it has completed the acquisition of Bestewil Holding B.V. and its subsidiary, Virosome Biologicals B.V., from Norwood Immunology Limited (LSE:NIM) as per the terms of the LOI described in the form 8-k filed on March 5, 2009. The Mymetics Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5478 Safe Harbor Forward-Looking Statements: Statements contained in this release that are not strictly historical are "forward-looking statements". Such forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects" and "hopes". The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission. CONTACT: Mymetics Corporation North America Anthony Jessop, Senior Vice President 1 303 800 6606 anthony.jessop@mymetics.com Switzerland Mr. Ernest Luebke, Chief Financial Officer 41 22 363 1310 Ernest.luebke@mymetics.ch
Mymetics Corporation Completes Important Acquisition
| Source: Mymetics Corporation